Study of MGL-3196 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)
Trial details
- Registry ID
- NCT03038022
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study of MGL-3196 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)NCT03038022 | MDGL | Phase 2 | Completed | 2018-01-15Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |